Life Sciences Rise In Value Despite Venture Capital Dropoff

Law360, New York (September 11, 2012, 9:18 PM EDT) -- Valuations for life science companies have moved upward this year despite a falloff in venture capital investment, according to Fenwick & West LLP's survey of venture capital financings for 186 U.S.-based life sciences companies.

The firm's First Half 2012 Life Science Venture Capital Survey found that up rounds — a round of funding in which the company's share price has increased since its prior financing round — outpaced down rounds 53 to 19 percent during the first half of 2012. The numbers are an improvement over...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.